Health Care

The Supreme Court upheld it, but the health-care industry still remains uncertain about the impact of President Obama's landmark health-care reform.

A federal jury in Delaware on Thursday ordered Gilead Sciences Inc. to pay $2.5 billion in damages to Merck & Co. for infringing its patents in developing hepatitis C drugs.

Eli Lilly shares are up sharply after it laid out a better-than-expected 2017 forecast nearly a month after it had announced the failure of a key Alzheimer's treatment in testing.

Connecticut and 19 other states filed a lawsuit on Thursday against Mylan NV, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general's office said in a statement.

Pilloried for their role in the epidemic of prescription painkiller abuse, drugmakers are aggressively pushing their remedy to the problem: a new generation of harder-to-manipulate opioids that have racked up billions in sales, even though there's little proof they reduce rates of overdoses or deaths.

Taxpayers will fork over nearly $10 billion more next year to cover double-digit premium hikes for subsidized health insurance under President Barack Obama's law, according to a study being released Thursday.

Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended to reduce medication costs.

Opinion: Putting this deal together will test the new president’s skills in the 'art of the deal' as real estate never could.

Cuisinart is voluntarily recalling about 8 million food processors after dozens of consumers reported finding pieces of broken blades in their food.

Food giant ConAgra is paying for a salmonella outbreak that sickened hundreds of Americans 10 years ago.

Johnson & Johnson says it is ending talks to buy Swiss drugmaker Actelion Pharmaceuticals.

A federal judge is scheduled to consider an $11.2 million plea deal to settle a criminal case against ConAgra stemming from a salmonella outbreak linked to the company's Peter Pan peanut butter that sickened hundreds a decade ago.

A Nebraska group said Tuesday that it's working with its founder, Gov. Pete Ricketts, to eliminate what it considers cumbersome job-licensing requirements that create a drag on the state economy.

The Latest on ConAgra's plead deal to settle a criminal case stemming from a 2006 salmonella outbreak (all times local): 1:30 p.m.

A key Republican lawmaker wants to overhaul the nation's Social Security program, proposing to gradually increase the retirement age and slow the growth of benefits for higher-income workers.

A French association of people affected by a drug that caused birth defects has launched a class action against pharmaceutical company Sanofi.

In the global fight to eradicate HIV/AIDS, one fundraising organization is harnessing the Cloud.

Flexion Therapeutics, Kite Pharma, and Agios Pharma all have drugs that could make their way to the FDA in the coming months.